Longman L P, Martin M V
School of Dental Surgery, University of Liverpool, U.K.
J Antimicrob Chemother. 1987 Nov;20(5):719-24. doi: 10.1093/jac/20.5.719.
The efficacy of amphotericin B, 5-fluorocytosine and itraconazole was compared for the treatment of experimental rabbit Aspergillus fumigatus endocarditis. Therapy with amphotericin B or 5-fluorocytosine, at dosages of 3.0 and 35 mg/kg body weight respectively, failed to eradicate aspergillus from the cardiac vegetations in all but one of the animals tested; none of these animals survived for longer than nine treatment days. When similar doses of amphotericin and 5-fluorocytosine were administered concomittantly, 30% of the animals had sterile vegetations. Itraconazole at 2.5 and 3.5 mg/kg body weight was not successful; all the animals tested had infected vegetations and did not survive beyond nine days of therapy. In contrast, itraconazole at 5.0 mg/kg sterilised the endocardial vegetations and all these animals survived for 14 days. It is concluded that itraconazole may be useful in the treatment of aspergillus endocarditis.
比较了两性霉素B、5-氟胞嘧啶和伊曲康唑治疗实验性兔烟曲霉心内膜炎的疗效。分别以3.0和35mg/kg体重的剂量使用两性霉素B或5-氟胞嘧啶进行治疗,除一只受试动物外,其他所有动物心脏赘生物中的曲霉菌均未被根除;这些动物无一存活超过9个治疗日。当同时给予相似剂量的两性霉素和5-氟胞嘧啶时,30%的动物赘生物无菌。体重2.5和3.5mg/kg的伊曲康唑治疗未成功;所有受试动物的赘生物均被感染,且无一存活超过治疗9日。相比之下,体重5.0mg/kg的伊曲康唑使心内膜赘生物无菌,所有这些动物均存活了14天。结论是伊曲康唑可能对治疗曲霉菌心内膜炎有用。